AlphaMaven AlphaMaven

Inflexion’s Rosemont Pharmaceuticals to acquire Aytu BioPharma in take-private deal - PEI Private Equity

Reported by Private Equity International
Nov 17, 2026· 1 min read
Save Post LinkedIn Email
Inflexion’s Rosemont Pharmaceuticals to acquire Aytu BioPharma in take-private deal  PEI Private Equity

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Private Equity International Inflexion’s Rosemont Pharmaceuticals to acquire Aytu BioPharma in take-private deal - PEI Private Equity